Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease

被引：0
|
作者：
Yoshifuru Tamura
Masahiro Kosuga
Masahiro Yamashita
Satoru Tomioka
Michiko Sasaki
Tomoyuki Hikita
Hideaki Nakajima
Kenichiro Kojima
Shunya Uchida
机构：
[1] Teikyo University School of Medicine,Division of Nephrology, Department of Internal Medicine
来源：
Clinical and Experimental Nephrology | 2008年 / 12卷
关键词：
Angiotensin II receptor blocker; Candesartan cilexetil; Chronic kidney disease; Hypertension; Renoprotective effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：256 / 263
页数：7
相关论文
共 50 条
  • [41] EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO BACKGROUND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER DOSE
    Heerspink, Hiddo Lambers
    Jong, Niels
    Stefansson, Bergur
    Chertow, Glenn
    Langkilde, Anna Maria
    Mcmurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Toto, Robert
    Wheeler, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I847 - I848
  • [42] Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
    Wu, Vin-Cent
    Lin, Yu-Feng
    Teng, Nai-Chi
    Yang, Shao-Yu
    Chou, Nai-Kuan
    Tsao, Chun-Hao
    Chen, Yung-Ming
    Chueh, Jeff S.
    Chen, Likwang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
    Huang Rong-Shuang
    Cheng Yi-Ming
    Zeng Xiao-Xi
    Kim Sehee
    Fu Ping
    中华医学杂志英文版, 2016, 129 (05) : 562 - 569
  • [44] Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
    Huang, Rong-Shuang
    Cheng, Yi-Ming
    Zeng, Xiao-Xi
    Kim, Sehee
    Fu, Ping
    CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 562 - 569
  • [45] Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease
    Guney, Ibrahim
    Selcuk, N. Yilmaz
    Altintepe, Lutfullah
    Atalay, Huseyin
    Basarali, M. Kemal
    Buyukbas, Sadik
    RENAL FAILURE, 2009, 31 (09) : 779 - 784
  • [46] Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis - a randomized study
    Takahashi, Akihiko
    Takase, Hiroyuki
    Toriyama, Takayuki
    Sugiura, Tomonori
    Kurita, Yutaka
    Ueda, Ryuzo
    Dohi, Yasuaki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2507 - 2512
  • [47] Tolerability and safety of high dose angiotensin II receptor blockade with candesartan cilexetil in combination with angiotensin converting enzyme inhibition in chronic heart failure
    Gradman, AH
    Flanagan, TL
    Michelson, EL
    CIRCULATION, 1999, 100 (18) : 783 - 783
  • [48] Renoprotective effects of telmisartan in patients with advanced chronic kidney disease
    Tokunaga, M.
    Kabashima, N.
    Serino, R.
    Shibata, T.
    Matsumoto, M.
    Miyamoto, T.
    Miyazaki, M.
    Furuno, Y.
    Nakamata, J.
    Fujimoto, Y.
    Takeuchi, M.
    Abe, H.
    Okazaki, M.
    Otsuji, Y.
    Tamura, M.
    CLINICAL NEPHROLOGY, 2010, 73 (02) : 139 - 146
  • [49] Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease
    Goicoechea, MA
    NEFROLOGIA, 2004, 24 (06): : 142 - 160
  • [50] Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
    Koh, KK
    Ahn, JY
    Han, SH
    Kim, DS
    Jin, DK
    Kim, HS
    Shin, MS
    Ahn, TH
    Choi, IS
    Shin, EK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 905 - 910
12345